Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Krallmann Group is a German-based specialist in plastics processing and toolmaking, primarily serving the medical technology, automotive, and industrial sectors. The company provides end-to-end services from product development and mold construction to high-precision injection molding and automated assembly. In the healthcare space, Krallmann produces complex components for diagnostic devices, laboratory equipment, and drug delivery systems, often utilizing cleanroom environments. Following a period of insolvency in late 2023, the company was acquired by the PPC Group in 2024, ensuring the continuation of its specialized manufacturing operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Krallmann Group.